1. "Gastrointestinal Oncology Service"
Formats
  1. Journal Article (2302)
  2. Meeting Abstract (1841)
  3. Review (139)
  4. Book Section (123)
  5. Editorial (93)
  6. Guidelines (36)
  7. Correspondence (33)
  8. Conference Paper (23)
  9. Miscellaneous (21)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)

More Groups

People
  1. Leonard Saltz (790)
  2. Eileen O'Reilly (780)
  3. Ghassan Abou-Alfa (568)
  4. Nancy Kemeny (543)
  5. David Kelsen (537)
  6. David Ilson (433)

More People

Years
  1. 2025 (118)
  2. 2024 (307)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1276)
  2. Annals of Oncology (320)
  3. Annals of Surgical Oncology (140)
  4. Cancer (127)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1355)
  2. Oxford University Press (447)
  3. Elsevier Inc. (404)
  4. Springer (310)
  5. American Association for Cancer Research (279)
  6. Wiley Blackwell (239)

More Publishers

Results (4640)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I/II multi-center study of nivolumab and carboplatin/paclitaxel with radiation therapy (RT) for patients with locally advanced esophageal squamous cell carcinoma (ESCC)
    Meeting Abstract

    Giuroiu, I.; Ku, G. Y.; Leichman, L. P.; Du, K. L.; Oh, P.; Levinson, B. A.; Iqbal, S.; Thomas, C. R.; Wu, J. J.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Phase Ib/II trial of durvalumab and chemoradiation (CRT) with carboplatin/paclitaxel for esophageal and gastroesophageal junction (GEJ) adenocarcinoma
    Meeting Abstract

    Greally, M.; Molena, D.; Sihag, S.; Wu, A. J. C.; Shah, P. M.; Fein, C.; Capanu, M.; Kelsen, D. P.; Janjigian, Y. Y.; Ilson, D. H.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC) who have received prior sorafenib: Results from the randomized phase III CELESTIAL trial
    Meeting Abstract

    Abou-Alfa, G. K.; Meyer, T.; Cheng, A. L.; El-Khoueiry, A. B.; Rimassa, L.; Ryoo, B. Y.; Cicin, I.; Merle, P.; Park, J. W.; Blanc, J. F.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Widespread somatic loss of heterozygosity as a possible marker of disease aggressiveness in metastatic well differentiated pancreatic neuroendocrine tumors
    Meeting Abstract

    Akala, O. O.; Shah, R.; Untch, B. R.; Kelly, V.; Chou, J. F.; Ladanyi, M.; Berger, M. F.; Klimstra, D. S.; Reidy, D. L.; Raj, N. P.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Grain intake and clinical outcome in stage III colon cancer: Results from CALGB 89803 (Alliance)
    Journal Article

    Brown, J. C.; Zhang, S.; Niedzwiecki, D.; Saltz, L. B.; Mayer, R. J.; Mowat, R. B.; Whittom, R.; Hantel, A.; Benson, A.; Atienza, D.; more...
    JNCI Cancer Spectrum (2018)

    Fulltext@MSK | Save
  • Medical therapy options for advanced disease in hepatocellular carcinoma
    Book Section

    El Dika, I.; Abou-Alfa, G. K.
    In Cardona, K.; Maithel, S. K. (Eds.) Primary and Metastatic Liver Tumors: Treatment Strategy and Evolving Therapies (2018)

    Fulltext@MSK | Save
  • Balancing RAF, MEK, and EGFR inhibitor doses to achieve clinical responses and modulate toxicity in BRAF V600E colorectal cancer
    Journal Article

    Mondaca, S.; Lacouture, M.; Hersch, J.; Yaeger, R.
    JCO Precision Oncology (2018)

    Fulltext@MSK | Save
  • Neoadjuvant and adjuvant therapy
    Book Section

    Greally, M.; Ku, G. Y.
    In Schlottmann, F.; Molena, D.; Patti, M. G. (Eds.) Esophageal Cancer: Diagnosis and Treatment (2018)

    Fulltext@MSK | Save
  • Safety and tolerability of the dual PI3K/mTOR inhibitor LY3023414 in treatment of patients with advanced mesothelioma
    Meeting Abstract

    Zauderer, M. G.; Hyman, D. M.; Alley, E. W.; Bendell, J. C.; Novello, S.; Bauer, T. M.; Hanauske, A. R.; Szpurka, A. M.; Kang, S.; Chatterjee, A.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • A phase I dose escalation study of trifluridine and tipiracil (FTD/TPI) in combination with irinotecan (IRI) in patients with advanced gastrointestinal (GI) tumors
    Meeting Abstract

    Varghese, A. M.; Cardin, D. B.; Hersch, J.; Benson, A. B.; Hochster, H. S.; Winkler, R.; Benedetti, F.; Hamada, K.; Berlin, J. D.; Saltz, L.
    Cancer Research (2018)

    Fulltext@MSK | Save